HCPEA Board of Directors

• T.J. Carella
• Mark Carter
• Andrew Cavanna
• Amy Christensen
• Christopher Crosby
• Geoff Lieberthal
• Ben Magnano
• John Maldonado
• Nicholas O'Leary
• Ravi Sachdev
• Doug Schillinger
• Anuska Sunder
• Paul Wallace

Paige Daly Partner, Harvest Partners Chairperson

Paige Daly is a Partner at Harvest Partners which she joined in 2010.  She concentrates on growth capital, buyout, and recapitalization investments in healthcare and consumer businesses. Prior to joining Harvest, Ms. Daly was a Partner at Apax Partners.

Ms. Daly has a BS in Economics from The Wharton School of the University of Pennsylvania and an MBA from Harvard Business School. She currently serves on the boards of Advance Dermatology and Dental Care Alliance.

Alex Albert Founding Partner, Patient Square Capital Vice Chairperson

Alex Albert is a Founding Partner of Patient Square Capital. He has over 15 years of investment and acquisition experience. Prior to joining Patient Square, Albert was a Partner at Ares Management where he served as the co-head of healthcare within the Private Equity Group. Most recently, Albert served on the Board of Directors of the parent entities of DuPage Medical Group, National Veterinary Associates, Ob Hospitalist Group and Unified Women's Healthcare. 

Albert holds a B.A., magna cum laude, from Vanderbilt University in Economics and an M.A. from Columbia University in Quantitative Methods. He also holds an M.Phil from Oxford University in Economics. Mr. Albert is a CFA® charterholder.

Thomas (T.J.) Carella Managing Director, Warburg Pincus Director

Thomas (TJ) Carella joined Warburg Pincus in 2016 where he is a Managing Director and focused on healthcare investing. Prior to joining Warburg Pincus, Mr. Carella was a partner in the Merchant Banking Division of Goldman Sachs and global head of the division’s private equity activities in the healthcare sector. While at Goldman Sachs, Mr. Carella led or was actively involved in investments including: Advanced Recovery Systems, Assuramed, Drayer Physical Therapy, Globus Medical, Golden State Medical Supply, iHealth Technologies, Magnacare, Press Ganey, Privia Health, T2Biosystems and Vitals Health. He currently serves as a Director of Alignment Healthcare and Specialist on Call. Mr. Carella earned a BA from Harvard College in 1997 and an MBA from Harvard Business School in 2004.

Mark Carter Managing Director, TA Associates Director

Mark is a member of TA’s Management, Core Investment and Portfolio Committees. He joined TA in 2005 and has more than 22 years of experience in the private equity and investment banking industries. While at TA, Mark has been responsible for leading numerous healthcare investments totaling more than $10 billion in enterprise value. He has deep expertise in the healthcare segment and has partnered with founders and management to accelerate growth through acquisitions, new product development and organic initiatives.

Andrew Cavanna Partner, Apax Partners Director

Andrew Cavanna is a Partner in the healthcare team. He joined Apax Partners in 2017 and is currently based in New York. Andrew has participated in key deals including Kepro, Genex and One Call Care Management.

Prior to joining Apax Partners, Andrew spent eleven years at Vestar Capital Partners where he was a Managing Director and Co-Head of the Healthcare Sector. At Vestar, Andrew was involved with a number of investments including Press Ganey, Essent Healthcare, StayWell, Joerns Healthcare, Sunrise Medical, Institutional Shareholder Services (ISS) and Veritas Collaborative. Andrew came to Vestar in 2006 from The Blackstone Group. Prior to Blackstone, Andrew was a Senior Associate at JPMorgan Partners. Andrew started his career as an Analyst in Leveraged Finance at Merrill Lynch.

Andrew holds an MBA from Columbia Business School and a BA, cum laude, in Economics and Government from Cornell University.

Andrew is a Board Member of the Darien Land Trust and the Cornell College of Arts and Sciences Advisory Council.

Amy Christensen Partner, The Vistria Group Director

Amy Christensen is a Partner with the Vistria Group. Prior to joining Vistria, Ms. Christensen was a Vice President at NewSpring Capital, a middle market private equity firm with a family of funds, including a dedicated healthcare fund.  At NewSpring she was responsible for the sourcing, due diligence, execution, and portfolio management of companies in a variety of industries including healthcare. Prior to NewSpring, Ms. Christensen was a Summer Associate with the Gores Group and an Associate with Calder Capital Partners. Ms. Christensen began her career with the Huron Consulting Group where she was responsible for designing, implementing, and managing key strategic and operational initiatives for large healthcare organizations.

Ms. Christensen currently serves on the Boards of Directors of Alacura, Chiro One, St. Croix Hospice, Supplemental Healthcare, and Behavioral Health Group.

Ms. Christensen received a B.S. from Northwestern University summa cum laude and an M.B.A. from The University of Chicago Booth School of Business where she was an Andrew Alper Merit Scholar.

Christopher Crosby Managing Director, Nautic Partners Director

Christopher J. Crosby is a Managing Director at Nautic Partners, LLC. He is a member of Nautic's Executive Committee and specializes on investing in the healthcare industry.  Prior to joining the firm in 2001, Mr. Crosby was a Principal with McCown De Leeuw and Co.  Prior to that, he worked for Indosuez Capital and Kidder, Peabody and Co., Inc.  Mr. Crosby holds an M.B.A. from Harvard Business School and a B.S. in Finance from Boston College.

Geoff Lieberthal Partner, Two Sigma Director

Geoff comes to Two Sigma from Lee Equity Partners, a U.S. growth buyouts firm, where he led the firm’s healthcare investments and served as a partner and member of the firm's Investment Committee.  Prior to Lee Equity, Geoff worked in the private equity funds of TPG Capital and Bain Capital and began his career as a consultant at Bain & Company. Geoff has been a director of several companies, including Summit BHC, Westfall Technik, Eating Recovery Centers, PDR Networks, Key Health, Paragon Industries, and Aptalis Pharma. Geoff was a faculty lecturer at Stanford Business School and is a member of the Board of Directors of the Healthcare Private Equity Association. Geoff is also a co-founder of Inspire Inc, a volunteer consulting non-profit organization, where he continues to serve as a director. Geoff received an M.B.A. from Stanford Business School and a B.A. in Engineering Sciences cum laude from Dartmouth College.

Ben Magnano Managing Partner, Frazier Healthcare Partners Director

Ben joined Frazier Healthcare Partners in 2006. He represents Frazier on the boards of CSafe Global, Caravel Autism Health, Comprehensive Pharmacy Services, Matrix Medical Network, Parata Systems and United Derm Partners. He also oversees human capital recruitment for Frazier’s Growth Buyout practice.  Prior to Frazier, Ben was an Associate at Morgan Stanley Capital Partners (MSCP), focusing on investing in the healthcare sector. Before joining MSCP, he was an Analyst in the Healthcare Investment Banking Group of Morgan Stanley. Earlier, he spent time at Arthur Andersen. Ben is also an Advisor for American Corporate Partners, a nationwide mentoring program dedicated to helping veterans transition to the private sector. He received his M.B.A from the Tuck School of Business at Dartmouth and his B.B.A. in Finance and Computer Applications from the University of Notre Dame.

John Maldonado Managing Partner, Advent International Director

John Maldonado joined Advent in 2006 focusing on buyouts in the healthcare, financial and business services sectors. His previous private equity experience includes positions at both Bain Capital and Parthenon Capital.  During his career, John has worked on 17 investments, 14 during his time at Advent, including ATI Physical Therapy Holdings, LLC, Cotiviti, Genoa Healthcare, Party City/Amscan, Skillsoft, Syneos Health, Inc., Vantiv (formerly Fifth Third Processing) and Worldpay.

John began his career as a Consultant with The Parthenon Group, a leading strategy consulting firm. He earned a BA, summa cum laude, from Dartmouth College and an MBA, with high distinction, as a Baker Scholar from Harvard Business School.

Nicholas O'Leary General Partner, Welsh, Carson, Anderson & Stowe Director

Mr. O'Leary is a General Partner, having joined WCAS in 2015. Prior to joining WCAS, Mr. O’Leary worked at JLL Partners for over six years, focused primarily on healthcare investments. Earlier in his career, he worked in the Mergers and Acquisitions group at Merrill Lynch.

Mr. O'Leary received a B.A. from Washington and Lee University.

Ravi Sachdev Partner, CD&R Director

Ravi Sachdev joined CD&R in 2015. He plays a key role in the Firm’s investments in agilon health, Vets First Choice, Tranzact and Healogics. Previously, he served as a Managing Director and Co-Head of Healthcare Services at J.P. Morgan, advising senior healthcare company executives on strategic initiatives, M&A and capital markets. In that role, Mr. Sachdev advised on multiple transactions including the sale of Medco to Express Scripts, Vanguard to Tenet, Trizetto to Cognizant and the IPOs of HealthEquity, SCA, Premier and IMS Health. He received his B.A. in economics from the University of Michigan.

Doug Schillinger Managing Director, DW Healthcare Partners Director

Doug is a Managing Director with DW Healthcare Partners. His investment and transaction experience includes bio-analytical/immune-analytical service laboratories, institutional and specialty pharmacies, medical device manufacturers in the cardiac and orthopedic markets, physician practice management companies, elder care service providers and clinical research organizations.

Before joining DW Healthcare Partners, Doug worked for Bain & Company. While there, Doug led strategic due diligence efforts as part of Bain’s Private Equity Group. Prior to joining Bain’s Private Equity Group, Doug advised Bain’s commercial clients in the consumer products and food service industries.

Doug received a Bachelors degree from Cornell University and an MBA with Distinction from Harvard Business School, and previously sat on the Harvard Business School Alumni Board of Directors.

		Anushka Sunder Managing Director, Blackstone Director
Anushka Sunder is a Managing Director in Blackstone’s Private Equity Group. Ms. Sunder focuses primarily on Blackstone’s private equity investments in healthcare and technology. Ms. Sunder serves on the Board of Directors of Blue Yonder, CARD, HealthEdge, Optiv, Precision Medicine Group, and TeamHealth and has also been actively involved in the execution of Blackstone’s investments in InComm, NCR, Outerstuff, and Signature Aviation. She is co-chair of the Blackstone Women’s Initiative task force and on the Blackstone Charitable Foundation Leadership Council.  Before joining Blackstone in 2013, Ms. Sunder was an associate at TPG Capital and an analyst at Goldman Sachs in the Financial Institutions Group. Ms. Sunder received an AB in Economics from Harvard College, where she graduated magna cum laude and Phi Beta Kappa, and an MBA from Harvard Business School. She is also a member of the Corporate Leaders Program at the Council on Foreign Relations.

Paul Wallace Managing Director, Heritage Group Director

Paul Wallace serves as Managing Director for Heritage Group. His prior experience includes more than 15 years in venture capital and private equity investing with firms such as GTCR, Lazard Asia, Gilbert Global, Petra Capital and SV Life Sciences.  He also spent 6 years leading corporate development for Healthways (NASDAQ: HWAY), during which time the company's revenue increased more than fivefold. He received his M.B.A. from Kellogg and his B.A. from the University of Richmond.  

He is a native of Nashville, where he resides with his wife and three children.